UTHealth Houston Gets Grant Funding to Develop Congenital Syphilis Test
A $3.3 million grant to develop a molecular diagnostic test for congenital syphilis has been awarded to researchers from UTHealth Houston.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Womens Health |
A $3.3 million grant to develop a molecular diagnostic test for congenital syphilis has been awarded to researchers from UTHealth Houston.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Clinical Chemistry Analyzers |
Carolina Liquid Chemistries Corp. now offers urine drug screens on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer.
Read MorePosted by Andy Lundin | Sep 12, 2023 | Cardiovascular |
The national program will reach about 30,000 primary care providers and cardiologists, and will assess the state of LDL screenings.
Read MorePosted by Andy Lundin | Sep 11, 2023 | Diagnostic Technologies |
The new novel method uses DNA Nanoballs to detect pathogens, and aims to simplify nucleic acid testing and revolutionize pathogen detection.
Read MorePosted by Andy Lundin | Sep 8, 2023 | Disease States |
Octave Bioscience announced the publication of the successful clinical validation of its Multiple Sclerosis Disease Activity (MSDA) Test.
Read More